カテゴリー： QYResearch, 世界

世界の組換えペプチド市場 2019年

【英語タイトル】Global Recombinant Peptides Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X14174）・商品コード：DATA909X14174
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、組換えペプチドの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グルカゴン、カルシトニン、その他に、用途別には、インスリン、ヒト成長ホルモン、血液製剤、その他にセグメント区分し、組換えペプチドの世界市場を分析しました。


・エグゼクティブ・サマリー
・組換えペプチドの世界市場概要
・組換えペプチドの製造コスト構成分析
・組換えペプチドの開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・組換えペプチドの地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・組換えペプチドのセグメント分析（種類別）
（グルカゴン、カルシトニン、その他）
・組換えペプチドのセグメント分析（用途別）
（インスリン、ヒト成長ホルモン、血液製剤、その他）
・組換えペプチドの主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Sandoz Pharma、Stada Arzneimittel、Amgen、Hospira、Actavis、Cipla Ltd.、Wockhardt Ltd.、Biocon Ltd.、）
・組換えペプチドの市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Recombinant Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Recombinant Peptides volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Peptides market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Peptides in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Recombinant Peptides manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Sandoz Pharma
Stada Arzneimittel
Amgen
Hospira
Actavis
Cipla Ltd.
Wockhardt Ltd.
Biocon Ltd.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Glucagon
Calcitonin
Other

Segment by Application
Insulin
Human Growth Hormone
Blood Products
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Recombinant Peptides
1.1 Definition of Recombinant Peptides
1.2 Recombinant Peptides Segment by Type
1.2.1 Global Recombinant Peptides Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Glucagon
1.2.3 Calcitonin
1.2.4 Other
1.3 Recombinant Peptides Segment by Applications
1.3.1 Global Recombinant Peptides Consumption Comparison by Applications (2014-2025)
1.3.2 Insulin
1.3.3 Human Growth Hormone
1.3.4 Blood Products
1.3.5 Other
1.4 Global Recombinant Peptides Overall Market
1.4.1 Global Recombinant Peptides Revenue (2014-2025)
1.4.2 Global Recombinant Peptides Production (2014-2025)
1.4.3 North America Recombinant Peptides Status and Prospect (2014-2025)
1.4.4 Europe Recombinant Peptides Status and Prospect (2014-2025)
1.4.5 China Recombinant Peptides Status and Prospect (2014-2025)
1.4.6 Japan Recombinant Peptides Status and Prospect (2014-2025)
1.4.7 Southeast Asia Recombinant Peptides Status and Prospect (2014-2025)
1.4.8 India Recombinant Peptides Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Recombinant Peptides
2.3 Manufacturing Process Analysis of Recombinant Peptides
2.4 Industry Chain Structure of Recombinant Peptides

3 Development and Manufacturing Plants Analysis of Recombinant Peptides
3.1 Capacity and Commercial Production Date
3.2 Global Recombinant Peptides Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Recombinant Peptides
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Recombinant Peptides Production and Capacity Analysis
4.2 Recombinant Peptides Revenue Analysis
4.3 Recombinant Peptides Price Analysis
4.4 Market Concentration Degree

5 Recombinant Peptides Regional Market Analysis
5.1 Recombinant Peptides Production by Regions
5.1.1 Global Recombinant Peptides Production by Regions
5.1.2 Global Recombinant Peptides Revenue by Regions
5.2 Recombinant Peptides Consumption by Regions
5.3 North America Recombinant Peptides Market Analysis
5.3.1 North America Recombinant Peptides Production
5.3.2 North America Recombinant Peptides Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Recombinant Peptides Import and Export
5.4 Europe Recombinant Peptides Market Analysis
5.4.1 Europe Recombinant Peptides Production
5.4.2 Europe Recombinant Peptides Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Recombinant Peptides Import and Export
5.5 China Recombinant Peptides Market Analysis
5.5.1 China Recombinant Peptides Production
5.5.2 China Recombinant Peptides Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Recombinant Peptides Import and Export
5.6 Japan Recombinant Peptides Market Analysis
5.6.1 Japan Recombinant Peptides Production
5.6.2 Japan Recombinant Peptides Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Recombinant Peptides Import and Export
5.7 Southeast Asia Recombinant Peptides Market Analysis
5.7.1 Southeast Asia Recombinant Peptides Production
5.7.2 Southeast Asia Recombinant Peptides Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Recombinant Peptides Import and Export
5.8 India Recombinant Peptides Market Analysis
5.8.1 India Recombinant Peptides Production
5.8.2 India Recombinant Peptides Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Recombinant Peptides Import and Export

6 Recombinant Peptides Segment Market Analysis (by Type)
6.1 Global Recombinant Peptides Production by Type
6.2 Global Recombinant Peptides Revenue by Type
6.3 Recombinant Peptides Price by Type

7 Recombinant Peptides Segment Market Analysis (by Application)
7.1 Global Recombinant Peptides Consumption by Application
7.2 Global Recombinant Peptides Consumption Market Share by Application (2014-2019)

8 Recombinant Peptides Major Manufacturers Analysis
8.1 Sandoz Pharma
8.1.1 Sandoz Pharma Recombinant Peptides Production Sites and Area Served
8.1.2 Sandoz Pharma Product Introduction, Application and Specification
8.1.3 Sandoz Pharma Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Stada Arzneimittel
8.2.1 Stada Arzneimittel Recombinant Peptides Production Sites and Area Served
8.2.2 Stada Arzneimittel Product Introduction, Application and Specification
8.2.3 Stada Arzneimittel Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Amgen
8.3.1 Amgen Recombinant Peptides Production Sites and Area Served
8.3.2 Amgen Product Introduction, Application and Specification
8.3.3 Amgen Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Hospira
8.4.1 Hospira Recombinant Peptides Production Sites and Area Served
8.4.2 Hospira Product Introduction, Application and Specification
8.4.3 Hospira Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Actavis
8.5.1 Actavis Recombinant Peptides Production Sites and Area Served
8.5.2 Actavis Product Introduction, Application and Specification
8.5.3 Actavis Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Cipla Ltd.
8.6.1 Cipla Ltd. Recombinant Peptides Production Sites and Area Served
8.6.2 Cipla Ltd. Product Introduction, Application and Specification
8.6.3 Cipla Ltd. Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Wockhardt Ltd.
8.7.1 Wockhardt Ltd. Recombinant Peptides Production Sites and Area Served
8.7.2 Wockhardt Ltd. Product Introduction, Application and Specification
8.7.3 Wockhardt Ltd. Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Biocon Ltd.
8.8.1 Biocon Ltd. Recombinant Peptides Production Sites and Area Served
8.8.2 Biocon Ltd. Product Introduction, Application and Specification
8.8.3 Biocon Ltd. Recombinant Peptides Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Recombinant Peptides Market
9.1 Global Recombinant Peptides Market Trend Analysis
9.1.1 Global Recombinant Peptides Market Size (Volume and Value) Forecast 2019-2025
9.2 Recombinant Peptides Regional Market Trend
9.2.1 North America Recombinant Peptides Forecast 2019-2025
9.2.2 Europe Recombinant Peptides Forecast 2019-2025
9.2.3 China Recombinant Peptides Forecast 2019-2025
9.2.4 Japan Recombinant Peptides Forecast 2019-2025
9.2.5 Southeast Asia Recombinant Peptides Forecast 2019-2025
9.2.6 India Recombinant Peptides Forecast 2019-2025
9.3 Recombinant Peptides Market Trend (Product Type)
9.4 Recombinant Peptides Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Recombinant Peptides Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Recombinant Peptides
Table Global Recombinant Peptides Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Recombinant Peptides Production Market Share by Types in 2018
Figure Glucagon Product Picture
Figure Calcitonin Product Picture
Figure Other Product Picture
Table Global Recombinant Peptides Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Recombinant Peptides Consumption Market Share by Applications in 2018
Figure Insulin
Figure Human Growth Hormone
Figure Blood Products
Figure Other
Figure Global Recombinant Peptides Revenue (Million USD) (2014-2025)
Figure Global Recombinant Peptides Production (K MT) (2014-2025)
Figure North America Recombinant Peptides Market Size (Million USD) (2014-2025)
Figure Europe Recombinant Peptides Market Size (Million USD) (2014-2025)
Figure China Recombinant Peptides Market Size (Million USD) (2014-2025)
Figure Japan Recombinant Peptides Market Size (Million USD) (2014-2025)
Figure Southeast Asia Recombinant Peptides Market Size (Million USD) (2014-2025)
Figure India Recombinant Peptides Market Size (Million USD) (2014-2025)
Table Recombinant Peptides Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Recombinant Peptides in 2018
Figure Manufacturing Process Analysis of Recombinant Peptides
Figure Industry Chain Structure of Recombinant Peptides
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Recombinant Peptides Manufacturing Plants Distribution
Table Recombinant Peptides Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Recombinant Peptides Capacity (K MT) of Major Manufacturers (2014-2019)
Table Recombinant Peptides Production (K MT) of Major Manufacturers (2014-2019)
Table Recombinant Peptides Production Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Peptides Production Share by Manufacturers in 2018
Table Recombinant Peptides Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Recombinant Peptides Revenue Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Peptides Revenue Share by Manufacturers in 2018
Table Recombinant Peptides Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Recombinant Peptides Production by Regions 2014-2019 (K MT)
Table Global Recombinant Peptides Production Market Share by Regions 2014-2019
Figure Global Recombinant Peptides Production Market Share by Regions in 2018
Table Global Recombinant Peptides Revenue by Regions 2014-2019 (Million USD)
Table Global Recombinant Peptides Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Peptides Revenue Market Share by Regions in 2018
Table Global Recombinant Peptides Consumption by Regions 2014-2019 (K MT)
Table Global Recombinant Peptides Consumption Market Share by Regions 2014-2019
Figure North America Recombinant Peptides Production Growth Rate 2014-2019 (K MT)
Figure North America Recombinant Peptides Revenue Growth Rate 2014-2019 (Million USD)
Table North America Recombinant Peptides Production, Consumption Import and Export (K MT)
Figure Europe Recombinant Peptides Production Growth Rate 2014-2019 (K MT)
Figure Europe Recombinant Peptides Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Recombinant Peptides Production, Consumption Import and Export (K MT)
Figure China Recombinant Peptides Production Growth Rate 2014-2019 (K MT)
Figure China Recombinant Peptides Revenue Growth Rate 2014-2019 (Million USD)
Table China Recombinant Peptides Production, Consumption Import and Export (K MT)
Figure Japan Recombinant Peptides Production Growth Rate 2014-2019 (K MT)
Figure Japan Recombinant Peptides Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Recombinant Peptides Production, Consumption Import and Export (K MT)
Figure Southeast Asia Recombinant Peptides Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Recombinant Peptides Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Recombinant Peptides Production, Consumption Import and Export (K MT)
Figure India Recombinant Peptides Production Growth Rate 2014-2019 (K MT)
Figure India Recombinant Peptides Revenue Growth Rate 2014-2019 (Million USD)
Table India Recombinant Peptides Production, Consumption Import and Export (K MT)
Figure Global Consumption Recombinant Peptides Market Share by Application (2014-2019)
Figure Global Value (Consumption) Recombinant Peptides Market Share by Application (2014-2019)
Table Sandoz Pharma Recombinant Peptides Production Sites and Area Served
Table Sandoz Pharma Recombinant Peptides Product Introduction, Application and Specification
Table Sandoz Pharma Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Sandoz Pharma Recombinant Peptides Production Growth Rate (2014-2019)
Table Sandoz Pharma Recombinant Peptides Production Market Share (2014-2019)
Figure Sandoz Pharma Recombinant Peptides Revenue Market Share (2014-2019)
Table Sandoz Pharma Recombinant Peptides Main Business and Markets Served
Table Stada Arzneimittel Recombinant Peptides Production Sites and Area Served
Table Stada Arzneimittel Recombinant Peptides Product Introduction, Application and Specification
Table Stada Arzneimittel Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Stada Arzneimittel Recombinant Peptides Production Growth Rate (2014-2019)
Table Stada Arzneimittel Recombinant Peptides Production Market Share (2014-2019)
Figure Stada Arzneimittel Recombinant Peptides Revenue Market Share (2014-2019)
Table Stada Arzneimittel Recombinant Peptides Main Business and Markets Served
Table Amgen Recombinant Peptides Production Sites and Area Served
Table Amgen Recombinant Peptides Product Introduction, Application and Specification
Table Amgen Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Amgen Recombinant Peptides Production Growth Rate (2014-2019)
Table Amgen Recombinant Peptides Production Market Share (2014-2019)
Figure Amgen Recombinant Peptides Revenue Market Share (2014-2019)
Table Amgen Recombinant Peptides Main Business and Markets Served
Table Hospira Recombinant Peptides Production Sites and Area Served
Table Hospira Recombinant Peptides Product Introduction, Application and Specification
Table Hospira Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Hospira Recombinant Peptides Production Growth Rate (2014-2019)
Table Hospira Recombinant Peptides Production Market Share (2014-2019)
Figure Hospira Recombinant Peptides Revenue Market Share (2014-2019)
Table Hospira Recombinant Peptides Main Business and Markets Served
Table Actavis Recombinant Peptides Production Sites and Area Served
Table Actavis Recombinant Peptides Product Introduction, Application and Specification
Table Actavis Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Actavis Recombinant Peptides Production Growth Rate (2014-2019)
Table Actavis Recombinant Peptides Production Market Share (2014-2019)
Figure Actavis Recombinant Peptides Revenue Market Share (2014-2019)
Table Actavis Recombinant Peptides Main Business and Markets Served
Table Cipla Ltd. Recombinant Peptides Production Sites and Area Served
Table Cipla Ltd. Recombinant Peptides Product Introduction, Application and Specification
Table Cipla Ltd. Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Cipla Ltd. Recombinant Peptides Production Growth Rate (2014-2019)
Table Cipla Ltd. Recombinant Peptides Production Market Share (2014-2019)
Figure Cipla Ltd. Recombinant Peptides Revenue Market Share (2014-2019)
Table Cipla Ltd. Recombinant Peptides Main Business and Markets Served
Table Wockhardt Ltd. Recombinant Peptides Production Sites and Area Served
Table Wockhardt Ltd. Recombinant Peptides Product Introduction, Application and Specification
Table Wockhardt Ltd. Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Wockhardt Ltd. Recombinant Peptides Production Growth Rate (2014-2019)
Table Wockhardt Ltd. Recombinant Peptides Production Market Share (2014-2019)
Figure Wockhardt Ltd. Recombinant Peptides Revenue Market Share (2014-2019)
Table Wockhardt Ltd. Recombinant Peptides Main Business and Markets Served
Table Biocon Ltd. Recombinant Peptides Production Sites and Area Served
Table Biocon Ltd. Recombinant Peptides Product Introduction, Application and Specification
Table Biocon Ltd. Recombinant Peptides Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Biocon Ltd. Recombinant Peptides Production Growth Rate (2014-2019)
Table Biocon Ltd. Recombinant Peptides Production Market Share (2014-2019)
Figure Biocon Ltd. Recombinant Peptides Revenue Market Share (2014-2019)
Table Biocon Ltd. Recombinant Peptides Main Business and Markets Served
Figure Global Recombinant Peptides Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Recombinant Peptides Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Recombinant Peptides Sales Price (USD/MT) Forecast 2019-2025
Figure North America Recombinant Peptides Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Recombinant Peptides Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Recombinant Peptides Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Recombinant Peptides Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Recombinant Peptides Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Recombinant Peptides Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Recombinant Peptides Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Recombinant Peptides Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Recombinant Peptides Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Recombinant Peptides Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Recombinant Peptides Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Recombinant Peptides Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Recombinant Peptides by Type (2019-2025)
Table Global Consumption (K MT) of Recombinant Peptides by Application (2019-2025)
Table Recombinant Peptides Distributors List
Table Recombinant Peptides Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Sandoz Pharma、Stada Arzneimittel、Amgen、Hospira、Actavis、Cipla Ltd.、Wockhardt Ltd.、Biocon Ltd.、

★調査レポート[世界の組換えペプチド市場 2019年] (コード：DATA909X14174)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の組換えペプチド市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の抗菌ペプチド市場 2019年
    DATA909X03657 / QYResearch / 2019年11月15日 / ※本調査レポートは、抗菌ペプチドの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、植物抗菌ペプチド、細菌抗菌ペプチド、動物抗菌ペプチド、昆虫抗菌ペプチドに、用途別には、製薬＆ヘルスケア、農業、生物工学にセグメント区分し、抗菌ペプチドの世界市場を分析しました。 ・エグゼクティブ・サマリー ・抗菌ペプチドの世界市場概要 ・抗菌ペプチドの製造コスト構成分析 ・抗菌ペプチドの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・抗菌ペプチドの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・抗菌ペプチドのセグメント分析（種類別） （植物抗菌ペプチド、細菌抗菌ペプチド、動物抗菌ペプチド、昆虫抗菌ペプチド）...The global Antimicrobial Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Antimicrobial Peptides volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antimicrobial Peptides market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Antimicrobial Peptides in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Antimicrobial Peptides manufacturing...
  • 世界の組み換えヒトエンドスタチン市場 2019年
    DATA909X14173 / QYResearch / 2019年11月20日 / ※本調査レポートは、組み換えヒトエンドスタチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、純度：95％、その他に、用途別には、医療、科学研究、その他にセグメント区分し、組み換えヒトエンドスタチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・組み換えヒトエンドスタチンの世界市場概要 ・組み換えヒトエンドスタチンの製造コスト構成分析 ・組み換えヒトエンドスタチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組み換えヒトエンドスタチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組み換えヒトエンドスタチンのセグメント分析（種類別） （純度：95％、その他）...The global Recombinant Human Endostatin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Human Endostatin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Human Endostatin market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Human Endostatin in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のペプチド市場 2019年
    DATA909X12782 / QYResearch / 2019年11月20日 / ※本調査レポートは、ペプチドの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、インスリン、テリパラチド、リラグルチド、ロイプロリドに、用途別には、糖尿病、感染症、がん、骨粗鬆症にセグメント区分し、ペプチドの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ペプチドの世界市場概要 ・ペプチドの製造コスト構成分析 ・ペプチドの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ペプチドの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ペプチドのセグメント分析（種類別） （インスリン、テリパラチド、リラグルチド、ロイプロリド）...The global Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Peptides volume and value at global level, regional level and company level. From a global perspective, this report represents overall Peptides market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Peptides in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Peptides manufacturing sites, capacity, production, ex-factory price,...
  • 世界のペプチド及びヘパリン市場 2019年
    DATA909X12781 / QYResearch / 2019年11月20日 / ※本調査レポートは、ペプチド及びヘパリンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、インスリン、テリパラチド、リラグルチド、ロイプロリド、ロイプロリド、エクセナチド、カルシトニン、エナキサパリンナトリウム、ヘパリンナトリウムに、用途別には、糖尿病、感染症、がん、骨粗鬆症にセグメント区分し、ペプチド及びヘパリンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ペプチド及びヘパリンの世界市場概要 ・ペプチド及びヘパリンの製造コスト構成分析 ・ペプチド及びヘパリンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ペプチド及びヘパリンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ペプチド及びヘパリンのセグメント分析（種類別） （インスリン、テリパラチド、リラグルチド、ロイプロリド、ロイプロリド、エクセナチド、カルシトニン、エナキサパリンナトリウム、ヘパリンナトリウム）...The global Peptides and Heparin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Peptides and Heparin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Peptides and Heparin market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Peptides and Heparin in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の組換体抗体市場 2019年
    DATA909X14170 / QYResearch / 2019年11月20日 / ※本調査レポートは、組換体抗体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、キメラ抗体、ヒト化抗体、完全ヒト抗体、単鎖抗体、二重特異性抗体に、用途別には、病院、科学研究、その他にセグメント区分し、組換体抗体の世界市場を分析しました。 ・エグゼクティブ・サマリー ・組換体抗体の世界市場概要 ・組換体抗体の製造コスト構成分析 ・組換体抗体の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組換体抗体の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組換体抗体のセグメント分析（種類別） （キメラ抗体、ヒト化抗体、完全ヒト抗体、単鎖抗体、二重特異性抗体）...The global Recombinant Antibody market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Antibody volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Antibody market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Antibody in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Recombinant Antibody manufacturing...
  • 世界の組換え第VIII因子市場 2019年
    DATA909X14171 / QYResearch / 2019年11月20日 / ※本調査レポートは、組換え第VIII因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、200IU、250IUに、用途別には、病院、薬局にセグメント区分し、組換え第VIII因子の世界市場を分析しました。 ・エグゼクティブ・サマリー ・組換え第VIII因子の世界市場概要 ・組換え第VIII因子の製造コスト構成分析 ・組換え第VIII因子の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組換え第VIII因子の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組換え第VIII因子のセグメント分析（種類別） （200IU、250IU）...The global Recombinant Factor VIII market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Factor VIII volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Factor VIII market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Factor VIII in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の組換えヒルジン薬市場 2019年
    DATA909X14172 / QYResearch / 2019年11月20日 / ※本調査レポートは、組換えヒルジン薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、12000 ATU / mg、16000 ATU / mg、16000 ATU / mg、その他に、用途別には、血栓症、腫瘍疾患、その他にセグメント区分し、組換えヒルジン薬の世界市場を分析しました。...The global Recombinant Hirudin Medicine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Hirudin Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Hirudin Medicine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Hirudin Medicine in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆